ExtremitiesSports Medicine

Lazurite® Names Physicians to Medical Advisory Board

CLEVELAND– February 23, 2023 (BUSINESS WIRE)–Medical device and technology company Lazurite today announced that Laith Jazrawi, M.D. and Mark Schickendantz, M.D. have joined the company’s medical advisory board.

Dr. Jazrawi is a professor of surgery with the department of orthopedic surgery at NYU Grossman School of Medicine and the chief of the division of sports medicine at NYU Langone. He serves as a team physician for the NYU and Long Island University athletics organization. His clinical research focuses on improving treatments for complex problems affecting the shoulder, elbow, and knee. He performed the first-in-man surgery using the ArthroFree System in September 2022.

Laith Jazrawi, M.D.

Dr. Schickendantz is an orthopedic sports medicine surgeon at the Cleveland Clinic and Professor of Surgery at the Cleveland Clinic Lerner College of Medicine. He serves as Head Team Physician and Director of Orthopedic Services for the Cleveland Guardians.

Mark Schickendantz, M.D. 

“We are delighted to have Drs. Jazrawi and Schickendantz join our team,” Lazurite CEO and cofounder Eugene Malinskiy said. “They have both added tremendous value in the product refinement of the ArthroFree® Wireless Surgical Camera System for our first target market of orthopedics and, particularly sports medicine.”

The ArthroFree System is the first wireless surgical camera to receive market clearance from the U.S. Food and Drug Administration for arthroscopy and general endoscopy. By eliminating conventional camera cables that tether surgeons to the surgical tower and hinder their movement, the ArthroFree System is expected to increase OR efficiency, improve OR safety and lower customer costs. More than 75 surgeries have now been performed using the ArthroFree System.

“I’ve had the opportunity to use the ArthroFree camera in numerous surgeries in the last several months and provide feedback to the Lazurite team,” Jazrawi said. “I look forward to joining the advisory board and helping to launch the era of wireless visualization in surgery.”

“I’m excited about joining the Lazurite team as the company brings the ArthroFree System to market,” Schickendantz said.

Jazrawi earned his medical degree from Icahn School of Medicine at Mt. Sinai in New York. He completed his residency in orthopedic surgery at NYU Medical Center and held a fellowship in Sports Medicine at American Sports Medicine Institute in Alabama. He is a member of a number of professional and medical societies, including the American Board of Orthopedic Surgery, the Arthroscopy Association of North America, and the American Orthopaedic Society for Sports Medicine. He is a fellow with the American Academy of Orthopedic Surgeons. He has a strong research interest in arthroscopic techniques, shoulder, elbow and knee disorders, cartilage repair, running injuries and maximizing athletic performance and has published nearly 300 peer-reviewed articles. He is the principal investigator on a comparative analysis study of the clinical use of the ArthroFree® Wireless Surgical Camera compared to wired surgical cameras.

Schickendantz earned his medical degree from Saint Louis University School of Medicine in St. Louis. He completed an internship in general surgery and residency in orthopedic surgery at Cleveland Clinic and held a fellowship in shoulder surgery and sports medicine at the Steadman Hawkins Clinic in Vail, Colo. He is a member of a number of professional and medical societies, including the American Board of Orthopedic Surgery, a fellow with the American Academy of Orthopedic Surgeons and the Major League Baseball Team Physicians Association, among many others. He has published nearly 100 peer-reviewed articles, has written book chapters and has presented at various research meetings. He is an investor in Lazurite.

About Lazurite

Lazurite is a medical device and technology company. Its ArthroFree® System—the wireless camera for arthroscopy and general endoscopy—is designed for surgeons seeking surgical tools for greater agility in the OR. ArthroFree is drop-in compatible with current OR technologies, and it promises to eliminate cable-related patient burns, OR fires, and staff trips and falls. With the ArthroFree System, Lazurite ushers in the wireless era of surgical visualization. Lazurite’s intellectual property portfolio also includes the low-heat Meridiem light technology and products in development. The pre-revenue company is located in Cleveland, OH (est. 2015), and to date has raised ~$25M from institutional investors, family offices, and more than 70 physician champions. The mission: solve impossible problems to improve people’s lives. The 10-year vision: better outcomes for 1 million patients—and thousands of clinicians, too. For more information, see: https://lazurite.co

Forward-Looking Statements

This press release includes “forward-looking statements.” Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “expect,” “may,” “should,” “will,” “designed,” “promises,” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the expected impact of the ArthroFree System on the field of minimally invasive surgery, and particularly arthroscopic surgery, and our future sales of the ArthroFree System. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Lazurite®, ArthroFree®, and Meridiem® are registered trademarks of Lazurite Holdings LLC.

Media Center

Visit lazurite.co/mediafor videos, logos, images, fact sheets, bios and more.


Patrick Gallagher
+1 (216) 233-7473

+1 (216) 334-3127

Photo: Business Wire

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button